NCT00617513View on ClinicalTrials.gov

Efficacy and Safety Study of Prucalopride for the Treatment of Chronic Constipation

PHASE2CompletedINTERVENTIONAL

Enrollment

174

Participants

Timeline

Start Date

March 31, 1995

Primary Completion Date

March 31, 1996

Study Completion Date

March 31, 1996

Conditions

Constipation

Interventions

DRUG

Prucalopride

0.5 mg once daily

OTHER

Placebo

o.d.

DRUG

Prucalopride

1 mg o.d.

DRUG

Prucalopride

2 mg o.d.

Sponsors

Lead Sponsor

All Listed Sponsors

lead

Movetis

INDUSTRY